Plain-English translation of NCT06842186 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called that is given as an injection under the skin. Researchers want to see if this treatment is safe and whether it helps people manage their weight and blood sugar. The study has two main parts: first, testing different doses in people with overweight or obesity, and second, testing the treatment in people who have prediabetes or type 2 diabetes.
Current treatments for weight management and blood sugar control don't work well enough for everyone. Researchers hope this medication might offer a new option to help people lose weight and improve their metabolic health.
You likely qualify if…
You likely don't qualify if…
You will receive either the new medication or a placebo (inactive injection) under your skin. In the first part of the study, you'll get a single injection and be monitored. In the second part, you'll receive repeated injections over time if you qualify based on whether you have prediabetes or type 2 diabetes. You'll have regular clinic visits where researchers will check your safety, take blood samples, and measure how your body responds to the treatment.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
United States
Moldova
Romania
United Kingdom